Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |